0001415889-22-003752.txt : 20220404 0001415889-22-003752.hdr.sgml : 20220404 20220404174441 ACCESSION NUMBER: 0001415889-22-003752 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220401 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lim Bryant David CENTRAL INDEX KEY: 0001752888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31918 FILM NUMBER: 22804107 MAIL ADDRESS: STREET 1: C/O IDERA PHARMACEUTICALS, INC. STREET 2: 505 EAGLEVIEW BLVD., SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDERA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000861838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043072298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 4843481600 MAIL ADDRESS: STREET 1: 505 EAGLEVIEW BOULEVARD STREET 2: SUITE 212 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: HYBRIDON INC DATE OF NAME CHANGE: 19951211 4 1 form4-04042022_020430.xml X0306 4 2022-04-01 0000861838 IDERA PHARMACEUTICALS, INC. IDRA 0001752888 Lim Bryant David C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BOULEVARD, SUITE 212 EXTON PA 19341 false true false false SVP AND GENERAL COUNSEL Stock Option (Right to Buy) 0.535 2022-04-01 4 A 0 41500 0 A 2032-04-01 Common Stock 41500 41500 D The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer. /s/ Bryant D. Lim 2022-04-04